BSECompany UpdateFundraise13 Oct 2026
Chandra Bhagat Pharma Ltd
The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis.
Chandra Bhagat Pharma Ltd has received in-principle approval from BSE for the issue of 66,00,000 convertible warrants into 66,00,000 equity shares on a preferential basis.
BSEInsider Trading / SASTResults1 Oct 2026
Chandra Bhagat Pharma Ltd
Notice of Closure of Trading Window
Chandra Bhagat Pharma Ltd has closed its trading window for directors, officers, and key managerial personnel due to the announcement of its half-yearly financial results, which are expected to be announced on or after 30th September 2026.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed the BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
CHANDRA BHAGAT PHARMA LIMITED
CHANDRA BHAGAT PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Chandra Bhagat Pharma Limited has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
Chandra Bhagat Pharma Ltd
Disclosure under regulation 30 for resignation of Company Secretary & Compliance Officer.
Chandra Bhagat Pharma Ltd has announced the resignation of its Company Secretary & Compliance Officer, Ms. Rajani Dawani, due to personal reasons, effective September 30, 2026.
BSEAGM/EGMResults3 Sept 2026
Chandra Bhagat Pharma Ltd
Declaration of Voting Result along with Scrutinizer Report of Annual General Meeting of the company.
Chandra Bhagat Pharma Ltd has declared the voting result of its Annual General Meeting, with all four resolutions passed with requisite majority. The resolutions include the adoption of annual accounts, re-appointment of a director, increase in authorized share capital, and approval for issuance of convertible warrants. The voting results are available on the company's website.
BSEAGM/EGM1 Sept 2026
Chandra Bhagat Pharma Ltd
Gist of the Proceeding of the 23rd Annual General Meeting (''AGM'') of the Company held on Tuesday, September 01, 2026.
The 23rd Annual General Meeting (AGM) of Chandra Bhagat Pharma Ltd was held on September 1, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and the reappointment of a director and the issuance of convertible warrants were approved.
BSECompany Update20 Aug 2026
Chandra Bhagat Pharma Ltd
Please find attached the corrigendum of AGM notice.
Chandra Bhagat Pharma Ltd has issued a corrigendum to its AGM notice, providing an updated link to a compliance certificate for a proposed preferential issue of convertible warrants.
BSEAGM/EGMResults6 Aug 2026
Chandra Bhagat Pharma Ltd
Please find attached the notice of shareholders meeting scheduled on 1st September, 2026.
Chandra Bhagat Pharma Ltd has announced its 23rd Annual General Meeting scheduled for September 1, 2026, along with the submission of its annual report for the financial year 2025-26. The meeting will be held at the company's registered office in Mumbai, and the agenda includes the adoption of annual accounts, re-appointment of a director, and an increase in the authorized share capital.
BSEOthersResults6 Aug 2026
Chandra Bhagat Pharma Ltd
Annual Report 2025-26
Chandra Bhagat Pharma Ltd has submitted its Annual Report for the financial year 2025-26, along with the notice for its 23rd Annual General Meeting scheduled on September 1st, 2026. The report includes the company's financial statements, auditor's report, and other relevant information.
BSEBoard MeetingFundraise5 Aug 2026
Chandra Bhagat Pharma Ltd
Please find attached outcome of Board Meeting.
Chandra Bhagat Pharma Ltd has announced the outcome of its Board Meeting, where it approved the increase in authorized share capital, issue of convertible warrants, and other agenda items. The company also announced the details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSEBoard MeetingFundraise30 Jul 2026
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Fund raising through ....
Chandra Bhagat Pharma Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/08/2026 to consider and approve fund raising through preferential issue.
BSECompany UpdateRegulatory21 Jul 2026
Chandra Bhagat Pharma Ltd
Non-applicability of Corporate Governance Report
Chandra Bhagat Pharma Ltd has announced that it is not required to submit a Corporate Governance Report for the quarter ended June 30, 2026, as it falls under an exemption in SEBI's Listing Obligation and Disclosure Requirements Regulation, 2015.